Literature DB >> 2655684

Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients.

S K Gupta1, A Bakran, R W Johnson, M Rowland.   

Abstract

1. The pharmacokinetics of cyclosporin were studied in six renal transplant patients, following intravenous administration of 5 mg kg-1 infused over 3, 6 and 24 h. 2. Plasma, separated at 37 degrees C, was analysed for cyclosporin by h.p.l.c. 3. The data were described by a biexponential disposition model. 4. None of the disposition parameters (clearance, initial volume of distribution, half-lives) changed with the duration of infusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2655684      PMCID: PMC1379834          DOI: 10.1111/j.1365-2125.1989.tb05376.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.

Authors:  B Legg; M Rowland
Journal:  Pharm Res       Date:  1988-02       Impact factor: 4.200

2.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

Authors:  S K Gupta; B Legg; L R Solomon; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

4.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

5.  Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods.

Authors:  G C Yee; M S Kennedy; R Storb; E D Thomas
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

Review 6.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

  6 in total
  1 in total

1.  A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Maria Tavakoli Ardakani; Ali Tafazoli; Mahshid Mehdizadeh; Abbas Hajifathali; Simin Dadashzadeh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.